Cell Separation Technology Market Size, Share, Industry Report by 2028

Cell Separation Technology Market: Industry Perspective

The global cell separation technology market size was worth around USD 4.5 billion in 2021 and is predicted to grow to around USD 8.01 billion by 2028 with a compound annual growth rate (CAGR) of roughly 7.14% between 2022 and 2028.

The report analyzes the global cell separation technology market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the cell separation technology industry.

Request Free Sample

Cell Separation Technologies Market: Overview

Cell separation is one of the most powerful techniques in biological research, medical therapy, and biomedical research. Rise in the use of these technologies in tissue engineering as well as regenerative medicine fields will crop the expansion of cell separation technologies market. In addition to this, the technology underpins large number of explorations in cell biology and facilitates research in regenerative medicine, HIV pathogenesis, and cancer treatment. Furthermore, therapeutic cell separation enables launching of enriched cell population to patient requiring medical requirements of cells. Citing an instance, the separating of leukocytes by hematopoietic stem cells enrichment or through aphaeresis.  

Furthermore, cell separation technology facilitates cell enumeration within blood system of individual and can support immune system repopulation. In recent times, many of the regenerative therapies based on separation of cells are limited to bone marrow and blood marrow. Nevertheless, breakthroughs in stem cell treatment have exhibited true potential for clinical cell-based treatments through the use of cells extracted from adipose and intestine.

COVID-19 Impact Analysis

Researchers have experienced huge impacts on the SARS-2 COVID pandemic across the globe.  The health emergency occurring across globe has resulted in the shutting down of many reputed scientific research labs. This has negatively affected the rapid expansion of the market. In spite of these impediments, the rising importance of cell sorting methods in gaining comprehensive insights into swift spread of COVID may augment economic recovery of business.

Scientists are highlighting the cataloging of virus-infected tissues of the human system for producing new kinds of therapeutic medicines for treating COVID. The potential use of cell separation technologies in COVID times can benefit industry growth in the ensuing years.

Request Free Sample

Cell Separation Technologies Market: Growth Dynamics

Large-scale use of highly selective cell separation technologies in clinical therapies and their ability of improving quality of cell repair along with ensuring best clinical results will drive cell separation technologies market surge. Rise in cell separation technologies by large number of researchers across globe has resulted in increment of market size in terms of both volume and revenue. Furthermore, surge in use of cell separation tools in bio-chemistry, physics, biology, electrical engineering, and materials science will drive growth of cell separation technologies market. Technological breakthroughs in cell-based techniques including high purity output and cell isolation will prop up revenue growth of cell separation technologies industry.

Moreover, rise in cases of cancer and other chronic ailments will result in humungous demand for cell separation technologies. With rise in research activities pertaining to neuroscience and immunology, the market for cell separation technologies is projected to gain traction over ensuing years.

Growing geriatric population coupled with rising prevalence of chronic diseases such as cancer are major driving factors for cell separation technologies market. Moreover, increasing government initiatives and technological advancement in the healthcare sectors are expected to have a positive impact on the cell separation technologies market. The emerging technologies in cell-based technology such as cell isolations, higher purity yield, time and cost effectiveness are expected to propel the market growth in the years to come. However, the high cost of cell separation tools may hamper the market growth in the near future. Nonetheless, the noteworthy technological advancements over the decade and their adoption in the medical sector are expected to open up new growth avenues in the years to come.

Cell Separation Technology Market: Report Scope

Cell Separation Technologies Market: Segmentation

The global cell separation technology market is segmented based on technology type, application, end-user, and region.

By Technology Type, the global is divided into immunomagnetic cell separation, fluorescence-activated cell sorting, density gradient centrifugation, microfluidic cell separation, and others. Separation based on surface markers and gradient centrifugation are the key technologies in the cell separation technology market. Separation based on surface marker technology is also bifurcated into Fluorescence Activated Cell Sorting (FACS) and Magnetic Activated Cell Sorting (MACS).  Separation based on surface marker technology dominated the global cell separation technology market owing to the faster results and accuracy level of results. Some of the key technologies such as gradient centrifugation techniques and FACS, chromatography sieving, panning, and lab on a chip are currently under development.

On the basis of application, the global cell separation technologies market can be segmented into stem cell research, immunology, neuroscience, cancer research, and others. The stem cell research segment was the leading segment and is expected to experience substantial growth within the forecast period. This growth is mainly attributed to the strong demand for cell therapies and the higher potential of stem cells in the stem cell research segment. Cancer research was another key outlet of this market. This growth is mainly due to increasing incidences of cancer and other cell-based diseases worldwide.

Cell Separation Technology Market: Report Scope

Cell Separation Technology Market: Regional Analysis

North America To Lead Cell Separation Technologies Market Growth Over 2022-2028

Expansion of the cell separation technologies industry in North America over the forecast timespan is subject to technological breakthroughs including cell isolation techniques. In addition to this, presence of giant industry players in the U.S. and Canada will make sizable contributions toward regional market size in the foreseeable future.

Furthermore, the Asia Pacific market is projected to record the fastest & sizable growth over forecast timespan owing to rise in awareness of chronic ailments in population. Supportive government policies will further augment regional market growth.

Recent Developments

• In October 2021, PerkinElmer, Inc. -  a Medtech firm based in the U.S.- declared launching of HIVE scRNAseq Solution in partnership with Honeycomb Biotechnologies, Inc. Reportedly, the new solution is designed for single-cell analysis & isolation.
• In February 2021, Thermo Fisher Scientific Corporation – a global leader in serving science- announced acquiring of Bigfoot spectral cell sorter & cell sorting technology assets from Propel Labs for bringing new sorting capabilities, new safety features, and rapid throughput.

Cell Separation Technology Market: Competitive Analysis

The global cell separation technology market is dominated by players like: 

• Carl Zeiss AG
• Lumenis Ltd.
• FEI Company
• Hamamatsu Photonics K.K.
• Becton, Dickinson, and Company
• Perkinelmer, Inc.
• Andor Technology Ltd
• Affymetrix Inc.
• Olympus Corporation of the Americas

The global cell separation technology market is segmented as follows;

By Technology Type

• Immunomagnetic Cell Separation
• Fluorescence-activated Cell Sorting
• Density Gradient Centrifugation
• Microfluidic Cell Separation
•  Others

By Application

• Stem Cell Research
• Immunology
• Neuroscience
• Cancer Research
• Others

 By End User

• Biotechnology & Pharmaceutical Companies
• Hospitals & Diagnostic Laboratories
• Academic & Research Institutes
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa